About 500 reports

One study tested the feasibility of muscle-directed gene therapy to prevent T##D through a recombinant adeno-associated virus (rAAV) vector containing murine circulating DNA for immunomodulatory cytokines IL-## or IL-##.

  • Chronic Disease
  • Diabetes
  • Insulin
  • Therapy
  • World

Gene Therapy in CVMD

7012 7995 6236
  • Oversight of Gene Therapy in China
  • COMPETITIVE ASSESSMENT OF KEY PLAYERS TARGETING CVMD INDICATIONS

I think one collapsed in Phase I and one in Phase II.

  • Chronic Disease
  • United States
  • AnGes MG, Inc.
  • Juventas Therapeutics, Inc.
  • ViroMed Co., Ltd.

SUPPLIER POWER -High ##.

  • Chronic Disease
  • World
  • Market Size
  • Amgen Inc.
  • Celgene Corporation

Gene therapy is really exciting. "

  • Chronic Disease
  • Forecast
  • Daiichi Sankyo Company
  • Depomed, Inc.
  • Pfizer Inc.
  • 6. GLOBAL BIOTECHNOLOGY MARKET ANALYSIS - BY TECHNOLOGY

Cancer is one of the major cause of death.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Forecast
  • Market Size

This collaboration focused on the development of BIIB##, an investigational AAV-based gene therapy for the treatment of XLRS, and BIIB##, an investigational AAV-based gene therapy for the treatment of XLRP.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Amgen Inc.
  • Antares Pharma, Inc.
  • EXPANSIONS

(US) with an aim to strengthen its position in gene therapy.

  • Biotech Diagnostics
  • Chronic Disease
  • North America
  • United States
  • Market Size
  • HEART FAILURE THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, PRECLINICAL, 2018
  • HEART FAILURE THERAPEUTICS MARKET, GLOBAL, ALL PIPELINE PRODUCTS, PHASE II, 2018

STEM CELL REPORTS; ##(##): ##-## ##(##): ##-## ##(##): ##-## IN CARDIOLOGY (JCARE-CARD).

  • Biotech Diagnostics
  • Chronic Disease
  • Market Size
  • Bristol-Myers Squibb Company
  • Les Laboratoires Servier SAS
  • U.S.A CELL EXPANSION MARKET
  • NORTH AMERICA CELL EXPANSION MARKET

INDUSTRY COMPETITION- MODERATE ##.

  • Cell Therapy
  • Chronic Disease
  • North America
  • World
  • Becton Property Group
  • REVENUE BY BUSINESS SEGMENTS 2017
  • 14.6 TAKARA BIO, INC.

The company views gene therapy segment as the foundation for future growth in terms of developing and commercializing gene therapies for diseases like cancer and others.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • CARDIOVASCULAR DISEASE DRUGS MARKET, GLOBAL, PIPELINE FOR KEY CARDIOVASCULAR
  • CARDIOVASCULAR DISEASE DRUGS MARKET, GLOBAL, PIPELINE BY STAGE OF DEVELOPMENT AND

Hypertension; ##(##): ## Johnston S, et al. (2016).

  • Chronic Disease
  • AstraZeneca PLC
  • Bristol-Myers Squibb Company
  • Merck & Co., Inc.
  • Pfizer Inc.
  • MICROARRAYS
  • KEY GROWTH STRATEGIES, (2015 - 2017)

TEL: +## ##-##-## FAX: +## ##-##-## WEBSITE: WWW. AGILENT. COM ##. ##. ## OVERVIEW AGILENT TECHNOLOGIES, INC.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Market Size
  • Agilent Technologies, Inc.

Cold Genesys, Amgen, VBL Therapeutics, Advantagene, and UniQure are some of the other companies developing gene therapies. ##. ##. ##. ## ##. ##. ## US TABLE ## The development of gene therapy requires an in-depth knowledge of gene expression, enabled by gene expression

  • Biotech Diagnostics
  • Chronic Disease
  • North America
  • United States
  • Illumina, Inc.
  • 6. GLOBAL GENOMICS MARKET ANALYSIS- BY TECHNOLOGY

TABLE ##.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • MARKET CHALLENGES
  • MARKET DRIVERS

The estimated spending for gene therapy was around $## million, gene therapy clinical trials was $## million, gene testing was $## million, and genetics was around $##, ## million.

  • Biotech Diagnostics
  • Chronic Disease
  • F. Hoffmann-La Roche Ltd.
  • Myriad Genetics, Inc.
  • QIAGEN N.V.

REGULATIONS THE PMD ACT IS ALSO KNOWN AS THE ACT ON SECURING QUALITY, EFFICACY AND SAFETY OF PHARMACEUTICALS, MEDICAL DEVICES, REGENERATIVE AND CELLULAR THERAPY PRODUCTS, GENE THERAPY PRODUCTS, AND COSMETICS.

  • Chronic Disease
  • World
  • Market Size
  • Becton Property Group
  • Medtronic, Inc.

TABLE ##.

  • Chronic Disease
  • Forecast
  • Market Size
  • Admedus Ltd
  • Biologics, Inc.

Gene Therapy Controversy Grows As Government, Patients Take Action ## Korea Suspends First Approved Gene Therapy Pending Component Discrepancy Probe ## Global Device Approvals Snapshot For March ##–April ##, 2019 ## PROBABILITY OF SUCCESS ## LICENSING AND ASSET ACQUISIT

  • Arthritis
  • Chronic Disease
  • Musculoskeletal Disorder
  • Pathology
  • World

The details ##.

  • Chronic Disease
  • World
  • Market Size
  • Masimo Corporation
  • Medtronic, Inc.
  • 5.4 EXPERT OPINIONS

One in four of these results in infertility.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Forecast
  • Market Size

The remainder of the pipeline comprises biologics, gene therapies, cell/ stem cell therapies, synthetic peptides, and oligonucleotides, indicating at least a small degree of innovation.

  • Chronic Disease
  • United States
  • World
  • Merck & Co., Inc.
  • Pfizer Inc.
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, PIPELINE BY KEY INDICATIONS AND
  • D) Pipeline by program type

DURING CHILDHOOD, ASTHMA IS MORE COMMON IN MALES, WITH A MALE-TO-FEMALE RATIO OF ##:## UP TO PUBERTY, WHEN IT CHANGES TO ##:##.

  • Biotech Diagnostics
  • Chronic Disease
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC

THIS ACQUISITION IS EXPECTED TO BOOST PFIZER' S GENE THERAPY PORTFOLIO BY COMBINING BAMBOO THERAPEUTICS' ADVANCED VECTOR DESIGN AND PRODUCTION TECHNOLOGIES.

  • Chronic Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG
  • Pfizer Inc.

Gene Therapy From GeneQuine ## Mitsubishi Seeks To Revoke Kolon Gene Therapy Deal But Damage Limited?

  • Arthritis
  • Chronic Disease
  • Pathology
  • World

FIGURE ##.

  • Biotech Diagnostics
  • Chronic Disease
  • Europe
  • Market Size
  • Agilent Technologies, Inc.

Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Pharmaceuticals and Healthcare No. of Deals ## ## ## ## ## ## Deal Value (US$ million) NA NA NA NA NA NA Note: Deals include all announced pharmaceuticals & healthcare

  • Chronic Disease
  • Mental Health
  • Neurological Disorder
  • Stroke
  • United States

FIGURE ##. ##.

  • Biotech Diagnostics
  • Chronic Disease
  • World
  • Forecast
  • Market Size
  • Strength 1 Low; 5 High
  • COMPETITIVE LANDSCAPE

The company leverages its wide operational network to maintain a revenue stream. ## Segment coverage ## ## ## ## R& D and manufacturing strength Marketing strength Strength ## Low; ## High Geographic coverage SANOFI: STRATEGY ASSESSMENT Assessment Strategy The company focuses on advanc

  • Biotech Diagnostics
  • Chronic Disease
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Pfizer Inc.
  • BY TECHNOLOGY

The recent progress in gene therapy triggers a hope to use genomics for various therapeutic applications.

  • Biotech Diagnostics
  • Chronic Disease
  • APAC
  • Agilent Technologies, Inc.
  • Danaher Corporation

THIS ACQUISITION IS EXPECTED TO BOOST PFIZER' S GENE THERAPY PORTFOLIO BY COMBINING BAMBOO' S ADVANCED VECTOR DESIGN AND PRODUCTION TECHNOLOGIES.

  • Beta-Blocker
  • Chronic Disease
  • AstraZeneca PLC
  • Gilead Sciences, Inc.
  • Novartis AG